Skip to main content
. Author manuscript; available in PMC: 2015 Oct 2.
Published in final edited form as: J Cardiovasc Transl Res. 2012 Nov 29;6(1):54–64. doi: 10.1007/s12265-012-9428-x

Fig. 3.

Fig. 3

Effect of p38 inhibitor, SB203580, on pro-atherogenic molecules and MCMV viral loads in aortas of MCMV-infected Apo E KO mice. a mRNA levels of adhesion molecules, MCP-1, p38, and ATF-2 in aortas of MCMV-infected, SB203580-treated vs. untreated mice; b mRNA levels of pro-inflammatory cytokines in aortas of MCMV-infected, SB203580-treated vs. untreated mice; c MCMV IE1 gene copies in aortas of MCMV-infected, SB203580-treated vs. untreated mice. Mice were treated four times, every 8 h for 24 h with SB203580. Values are average of n=10 mice per group. Significance (*) at p≤ 0.05